Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study-Reference-Cited by-同舟云学术

Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study

Published:2017-05-19 Issue:1 Volume:18 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Bell Samira^ORCID,Farran Bassam,McGurnaghan Stuart,McCrimmon Rory J.,Leese Graham P,Petrie John R,McKeigue Paul,Sattar Naveed,Wild Sarah,McKnight John,Lindsay Robert,Colhoun Helen M.,Looker Helen

Funder

Chief Scientist Office

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s12882-017-0579-5.pdf

Reference37 articles.

1. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD). Diabetes Care. 2012;35(6):1364–79.

2. Ekström N, Schiöler L, Svensson A, et al Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open. 2012;2:e001076. doi: 10.1136/bmjopen-2012-001076 .

3. Roumie CL, Hung AM, Greevy RA, Grijalva CG, Liu X, Murff HJ, Elasy TA, Griffin MR. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2012;157(9):601–10.

4. Roussel R, Travert F, Pasquet B, Wilson PW, Smith SC Jr, Goto S, Ravaud P, Marre M, Porath A, Bhatt DL, et al. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med. 2010;170(21):1892–9.

5. Hong J, Zhang Y, Lai S, Lv A, Su Q, Dong Y, Zhou Z, Tang W, Zhao J, Cui L, et al. Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. Diabetes Care. 2013;36(5):1304–11.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes;Diabetes, Obesity and Metabolism;2024-07-10

2. Metformin beyond type 2 diabetes: Emerging and potential new indications;Diabetes, Obesity and Metabolism;2024-07-04

3. Prevalence of metabolic syndrome among patients with type 2 diabetes mellitus: A cross-sectional study in a tertiary care center of western Nepal;2024-06-04

4. The latest emerging drugs for the treatment of diabetic cardiomyopathy;Expert Opinion on Pharmacotherapy;2024-04-12

5. Network Toxicology Prediction and Molecular Docking-based Strategy to Explore the Potential Toxicity Mechanism of Metformin Chlorination Byproducts in Drinking Water;Combinatorial Chemistry & High Throughput Screening;2024-01